Overview

G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

Status:
NOT_YET_RECRUITING
Trial end date:
2030-01-01
Target enrollment:
Participant gender:
Summary
The goal of this phase 2 trial is to test the safety and efficacy of G-Pola-ZLP as induction therapy in patients with DLBCL.
Phase:
PHASE2
Details
Lead Sponsor:
Navy General Hospital, Beijing
Treatments:
glofitamab
Lenalidomide
Neoadjuvant Therapy
polatuzumab vedotin
Prednisone
zanubrutinib